Dabur India units face lawsuits in US and Canada over Hair Relaxer Products
Dabur India units face lawsuits in US

Dabur India units face lawsuits: Dabur India, a prominent player in the fast-moving consumer goods (FMCG) sector, is involved in legal disputes involving three foreign subsidiaries. These cases revolve around allegations that hair relaxer products marketed by Dabur-owned companies have resulted in serious health issues, including ovarian and uterine cancer, among consumers. Namaste Laboratories LLC, Dermoviva Skin Essentials Inc., and Dabur International Ltd are the subsidiaries facing these lawsuits.

Dabur India units face lawsuits: The Legal Landscape

According to a regulatory filing by Dabur India, numerous hair relaxer product industry consumers have claimed that certain industry players, including Dabur’s subsidiaries, manufactured and sold hair relaxer products containing harmful chemicals. These chemicals, consumers allege, have led to the development of severe health issues. These health concerns include ovarian cancer, uterine cancer, and various other related health problems. Legal action has been initiated in federal and state courts in the United States and Canada.

The federal cases in the United States have been consolidated into a Multi-District Litigation (MDL), also known as MDL, which the United States District Court currently oversees for the Northern District of Illinois. This consolidation streamlines the legal process for efficiency and consistency.

Dabur India units face lawsuits: The Ongoing Legal Proceedings

At present, there are approximately 5,400 cases combined under the MDL, with Namaste Laboratories LLC, Dermoviva Skin Essentials Inc., and Dabur International Ltd named as defendants. Other industry players are also implicated in these legal proceedings. These cases are still in the early stages of litigation, encompassing pleadings and early discovery phases.

Legal experts have noted that during these initial stages of litigation, parties involved challenge the adequacy of the plaintiff’s complaints. Various motions are still pending, and extensive exchanges of requests for information and documents are ongoing. Dabur India has maintained that any financial implications related to settlements or verdict outcomes cannot be determined at this stage.

The Defense and Denial

On behalf of its subsidiaries, Dabur India has asserted that Namaste Laboratories LLC, Dermoviva Skin Essentials Inc., and Dabur International Ltd firmly deny any liability. These companies have retained legal counsel to mount a robust defense in response to the lawsuits. They argue that the allegations are based on unsubstantiated and incomplete studies; therefore, they lack a solid foundation.

The company has stated that it remains in the early stages of litigation, making it challenging to predict the eventual quantum of claim amounts. The ongoing legal proceedings and the defense strategy have raised expectations that defense costs for these cases will soon surpass the materiality threshold.

An Ongoing Legal Battle

As Dabur India units face lawsuits and its subsidiaries navigate this complex legal landscape, they remain resolute that the allegations lack merit and are not supported by conclusive evidence. While these legal challenges evolve, the ultimate financial implications and outcomes remain uncertain. In the backdrop of these legal battles, it is evident that the FMCG giant faces a significant test of its legal defenses in courts across the United States and Canada. The resolution of these cases will undoubtedly shape the future for Dabur India and the plaintiffs seeking redress for their alleged health issues.

Read More: IRCTC partners with Zomato to Transform Rail Travel Dining Experience